Skip to content
Sleep & circadian healthResearch article3 min read

Sleep problems, apnea symptoms and daytime sleepiness linked to higher inflammation index

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Analysis of the relationship between sleep-related disorder and systemic immune-inflammation index in the US population. · BMC psychiatry · 2023 · Original paper ↗

Key takeaway

Among 8,505 US adults in NHANES, reporting sleep problems, sleep apnea symptoms or daytime sleepiness was linked to a higher systemic immune-inflammation index (SII), for example β 30.320 for daytime sleepiness. Sleep was self-reported and measured once, so the data cannot show that poor sleep raises inflammation.

Study design

Research article

Reading basis

Published abstract

Reading focus

Design & applicability

The research question

Poor sleep has been tied to inflammation, but one newer blood-count measure, the systemic immune-inflammation index (SII), had not been examined against sleep problems. The authors tested whether self-reported sleep duration, sleep problems, high risk of obstructive sleep apnea (OSA) and daytime sleepiness relate to SII, and to two older markers, the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR).

Who and how

Cross-sectional analysis of the 2005-2008 National Health and Nutrition Examination Survey (NHANES), a nationally representative sample of non-hospitalized US adults, with 8,505 participants. Sleep duration, sleep problems, high risk of OSA and daytime sleepiness were self-reported. SII, PLR and NLR were the outcomes, analysed with multiple linear regression. Subgroup interactions were tested with likelihood ratio tests and nonlinear relationships with restricted cubic splines. The abstract does not list the adjustment variables.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Sleep disorders were more strongly associated with SII than with PLR or NLR.
  2. 2
    Higher SII (a larger index value) was linked to sleep problems (β 21.421; 95% CI 1.484 to 41.358), OSA symptoms (β 23.088; 95% CI 0.441 to 45.735) and daytime sleepiness (β 30.320; 95% CI 5.851 to 54.789).
  3. 3
    For the older markers, only daytime sleepiness was associated with a higher NLR (β 0.081; 95% CI 0.002 to 0.159).
  4. 4
    The confidence intervals for sleep problems and OSA symptoms come close to zero, so those estimates are imprecise.

Limits & uncertainty

  1. 1
    Exposure and outcome were captured at one point in time, so the direction of the link cannot be established; the authors call for prospective studies to test causation.
  2. 2
    Sleep duration, sleep problems, OSA risk and sleepiness were all self-reported, not measured with a sleep test.
  3. 3
    The abstract gives no absolute SII values for comparison, so the practical size of these β values is hard to judge.
  4. 4
    This reading is based on the abstract only.

What to take from it

People who sleep badly, snore or feel sleepy by day tend to have slightly higher blood-count inflammation scores, but this does not show that fixing sleep lowers them. SII is a lab calculation your doctor can run from a routine blood count; it is not a number to chase on its own. Persistent sleepiness or suspected sleep apnea is worth raising with a clinician.

Reading your own data

SII cannot be tracked from a wearable. What you can log is sleep duration, nightly disruptions and how sleepy you feel by day, compared against your own multi-week trend on the same device rather than single nights.

How to read this evidence

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

The association between sleep-related disorders and inflammation has been demonstrated in previous studies. The systemic immune-inflammation index (SII) is a novel inflammatory index based on leukocytes, but its relationship with sleep-related disorder is unclear. We aimed to investigate the relationship between sleep-related disorder and SII in a nationally representative nonhospitalized sample.

Methods

Data were obtained from the 2005-2008 National Health and Nutrition Examination Survey (NHANES). Exposure variables included self-reported sleep-related disorders, such as sleep duration, sleep problems, high risk of OSA, and daytime sleepiness. SII and other traditional markers of inflammation were considered as outcome variables, including platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR). Multiple linear regression models were employed to examine the correlation between sleep-related disorders and inflammatory markers. Subgroup interactions were analyzed using likelihood ratio tests, and nonlinear relationships were explored by fitting restricted cubic splines.

Results

A total of 8,505 participants were enrolled in this study. Overall, sleep-related disorders were found to have a stronger association with SII compared to the PLR and NLR. The results of multiple linear regression analysis revealed that participants who experienced sleep problems (β: 21.421; 95% CI 1.484, 41.358), had symptoms of OSA (β: 23.088; 95% CI 0.441, 45.735), and reported daytime sleepiness (β: 30.320; 95% CI 5.851, 54.789) exhibited a positive association with higher SII. For the analysis of other inflammatory markers, we only found that daytime sleepiness was associated with increased NLR levels (β: 0.081; 95% CI 0.002, 0.159).

Conclusion

Sleep problems, symptoms of OSA, and daytime sleepiness were found to have a positive association with the SII in US adults. However, further prospective studies are necessary to establish whether there is a causal relationship between these factors.

Sources & attribution

Analysis of the relationship between sleep-related disorder and systemic immune-inflammation index in the US population.

Kadier K, Dilixiati D, Ainiwaer A, Liu X, Lu J, Liu P, Ainiwan M, Yesitayi G, Ma X, Ma Y.

BMC psychiatry · 2023-10-24

DOI: 10.1186/s12888-023-05286-7 ↗PubMed · 37872570 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Trial meta-analysis

Exercise improved sleep-quality scores in adults 45 and older with sleep disorders

Pooling 23 randomized trials with 1,478 adults aged 45 to 77 who had sleep disorders, exercise improved Pittsburgh Sleep Quality Index scores (SMD 0.62, 95% CI 0.40–0.83), and aerobic exercise showed the largest effect in the network analysis (SMD 1.34, 95% CrI 0.86–1.82). Certainty was low to moderate, the outcomes were questionnaires, and the best weekly dose of about 539 MET-min/week is a model estimate, not a prescription.

Journal of Exercise Science & Fitness

In-depth explainersRead study →
·Cohort study

Sleep regularity tracked mortality more closely than sleep duration in 60,977 UK adults

Among 60,977 UK Biobank adults who wore a wrist accelerometer for a week, the most regular fifth of sleepers had a fully adjusted all-cause mortality HR of 0.70 (95% CI 0.59–0.83) against the least regular fifth, over about 6.3 years and 1859 deaths. Regularity fitted the data better than sleep duration, but the study is observational and rests on one week of sleep data.

Sleep

In-depth explainersRead study →
·Randomised trial

Sleep extension cut daily energy intake by about 270 kcal in adults with overweight

In 80 adults with overweight who usually slept under 6.5 hours, two weeks of sleep-extension counselling added about 1.2 hours of sleep and lowered measured energy intake by 270.4 kcal/d versus control (95% CI −393.4 to −147.4). The trial was short, single-centre and in a narrow group, so it does not show lasting weight loss or any benefit for people who already sleep enough.

JAMA Internal Medicine

In-depth explainersRead study →
·Cohort study

Six hours or less of sleep at 50 and 60 linked to higher dementia risk

In 7959 British civil servants followed for about 25 years, sleeping six hours or less at age 50 (HR 1.22, 95% CI 1.01–1.48) or age 60 (HR 1.37, 1.10–1.72) was linked to a higher dementia rate than sleeping seven hours, and persistent short sleep gave an HR of 1.30 (1.00–1.69). Sleep was mostly self-reported and the study is observational, so early brain disease or other factors may explain part of the link.

Nature Communications

In-depth explainersRead study →
Sleep & circadian health →